Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
In vitro antitumor effect of a lignan isolated from Combretum fruticosum, trachelogenin, in HCT-116 human colon cancer cells
Ist Teil von
Toxicology in vitro, 2018-03, Vol.47, p.129-136
Ort / Verlag
England: Elsevier Ltd
Erscheinungsjahr
2018
Quelle
ScienceDirect
Beschreibungen/Notizen
The use of natural products in therapeutics has been growing over the years. Lignans are compounds with large pharmaceutical use, which has aroused interest in the search for new drugs to treat diseases. The present study evaluated the cytotoxicity of (−)-trachelogenin, a dibenzylbutyrolactone type lignan isolated from Combretum fruticosum, against several tumor and non-tumor cell lines using the MTT assay and its possible mechanism of action. (−)-Trachelogenin showed IC50 values ranging of 0.8–32.4μM in SF-295 and HL-60 cell lines, respectively and IC50 values >64μM in non-tumor cell lines. (−)-trachelogenin persistently induced autophagic cell death, with cytoplasmic vacuolization and formation of autophagosomes mediated by increasing LC3 activation and altering the expression levels of Beclin-1.
•(−)-Trachelogenin was isolated from Combretum fruticosum.•Cytotoxicity of (−)-Trachelogenin was evaluated against tumor and non-tumor cells.•(−)-Trachelogenin induced cytoplasmic vacuolization and cell death.•Treated HCT-116 cells had chances in specific markers of autophagy.•The treatment with (−)-Trachelogenin induced autophagy in HCT-116 cells.